Search Results - "Feit, F"

Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors by Bangalore, Sripal, Toklu, Bora, Kotwal, Anupam, Volodarskiy, Alexander, Sharma, Sahil, Kirtane, Ajay J, Feit, Frederick

“…Objectives To investigate the relative benefits of unfractionated heparin, low molecular weight heparin(LMWH), fondaparinux, and bivalirudin as treatment…”
Get full text

Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience by Sloan, M A, Price, T R, Petito, C K, Randall, A M, Solomon, R E, Terrin, M L, Gore, J, Collen, D, Kleiman, N, Feit, F

“…Parenchymatous intracerebral hemorrhage (ICH) is a serious, infrequent complication of thrombolytic therapy for acute myocardial infarction. We studied the…”
Get full text

Percutaneous coronary artery intervention: The last five years and the next five years by Feit, Frederick

Get full text

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial by Bovill, E G, Terrin, M L, Stump, D C, Berke, A D, Frederick, M, Collen, D, Feit, F, Gore, J M, Hillis, L D, Lambrew, C T

“…To assess the effects of invasive procedures, hemostatic and clinical variables, the timing of beta-blocker therapy, and the doses of recombinant plasminogen…”
Get more information

Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction: report from the second Mount Sinai-New York University reperfusion trial by RENTROP, K. P, FEIT, F, SHERMAN, W, THORNTON, J. C

“…In the Second Mt. Sinai-New York University Reperfusion Trial, in which change of ejection fraction was the primary end point, the following secondary end…”
Get full text

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial by Mehran, Roxana, Pocock, Stuart J., Stone, Gregg W., Clayton, Tim C., Dangas, George D., Feit, Frederick, Manoukian, Steven V., Nikolsky, Eugenia, Lansky, Alexandra J., Kirtane, Ajay, White, Harvey D., Colombo, Antonio, Ware, James H., Moses, Jeffrey W., Ohman, E. Magnus

“…Aims To evaluate the associations of myocardial infarction (MI) and major bleeding with 1-year mortality. Both MI and major bleeding predict 1-year mortality…”
Get full text

Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials by Bangalore, Sripal, Kumar, Sunil, Fusaro, Mario, Amoroso, Nicholas, Kirtane, Ajay J, Byrne, Robert A, Williams, David O, Slater, James, Cutlip, Donald E, Feit, Frederick

“…Objectives To evaluate the efficacy and safety of currently used drug eluting stents compared with each other and compared with bare metal stents in patients…”
Get full text

Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial by Lincoff, A. Michael, Bittl, John A, Harrington, Robert A, Feit, Frederick, Kleiman, Neal S, Jackman, J. Daniel, Sarembock, Ian J, Cohen, David J, Spriggs, Douglas, Ebrahimi, Ramin, Keren, Gadi, Carr, Jeffrey, Cohen, Eric A, Betriu, Amadeo, Desmet, Walter, Kereiakes, Dean J, Rutsch, Wolfgang, Wilcox, Robert G, de Feyter, Pim J, Vahanian, Alec, Topol, Eric J

“…CONTEXT: The direct thrombin inhibitor bivalirudin has been associated with better efficacy and less bleeding than heparin during coronary balloon angioplasty…”
Get full text

Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization: REPLACE-2 Randomized Trial by Lincoff, A. Michael, Kleiman, Neal S, Kereiakes, Dean J, Feit, Frederick, Bittl, John A, Jackman, J. Daniel, Sarembock, Ian J, Cohen, David J, Spriggs, Douglas, Ebrahimi, Ramin, Keren, Gadi, Carr, Jeffrey, Cohen, Eric A, Betriu, Amadeo, Desmet, Walter, Rutsch, Wolfgang, Wilcox, Robert G, de Feyter, Pim J, Vahanian, Alec, Topol, Eric J, for the REPLACE-2 Investigators

“…CONTEXT In the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial, bivalirudin with provisional glycoprotein IIb/IIIa…”
Get full text

Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction by Rentrop, K P, Feit, F, Blanke, H, Stecy, P, Schneider, R, Rey, M, Horowitz, S, Goldman, M, Karsch, K, Meilman, H

“…We randomly assigned patients with a clinical diagnosis of acute myocardial infarction to one of four treatment groups: intracoronary streptokinase,…”
Get more information

Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: Primary end point findings of the second mount sinai-new york university reperfusion trial by Rentrop, K.Peter, Feit, Frederick, Sherman, Warren, Stecy, Peter, Hosat, Susan, Cohen, Marc, Rey, Mariano, Ambrose, John, Nachamie, Mark, Schwartz, William, Cole, William, Perdoncin, Robert, Thornton, John C.

“…The change in left ventricular ejection fraction from preintervention to predischarge was prospectively assessed in 393 patients with acute myocardial…”
Get full text

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study by Bittl, John A., Chaitman, Bernard R., Feit, Frederick, Kimball, William, Topol, Eric J.

“…Background This study was a reanalysis of the Bivalirudin Angioplasty Study, which compared bivalirudin with high-dose heparin during coronary angioplasty for…”
Get full text

Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale by Stone, Gregg W., Bertrand, Michel, Colombo, Antonio, Dangas, George, Farkouh, Michael E., Feit, Frederick, Lansky, Alexandra J., Lincoff, A.Michael, Mehran, Roxana, Moses, Jeffrey W., Ohman, Magnus, White, Harvey D.

“…Patients with acute coronary syndromes (ACS; unstable angina and non–ST-segment elevation myocardial infarction) are at significant risk for death and…”
Get full text

Atherosclerotic heart disease in the elderly by Keller, N M, Feit, F

“…The elderly represent an increasingly important and challenging subset of the population of patients with ischemic heart disease. They are more likely to have…”
Get more information

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial) by Lincoff, A.Michael, Bittl, John A, Kleiman, Neal S, Sarembock, Ian J, Jackman, J.Daniel, Mehta, Sameer, Tannenbaum, Mark A, Niederman, Alan L, Bachinsky, William B, Tift-Mann, J, Parker, H.Graham, Kereiakes, Dean J, Harrington, Robert A, Feit, Frederick, Maierson, Elizabeth S, Chew, Derek P, Topol, Eric J

“…To assess the efficacy of the direct thrombin inhibitor bivalirudin relative to heparin during contemporary coronary intervention, 1,056 patients who underwent…”
Get full text

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis by Bangalore, Sripal, Toklu, Bora, Amoroso, Nicholas, Fusaro, Mario, Kumar, Sunil, Hannan, Edward L, Faxon, David P, Feit, Frederick

“…Objective To compare the efficacy and safety of biodegradable polymer drug eluting stents with those of bare metal stents and durable polymer drug eluting…”
Get full text

Thrombolysis in Myocardial Infarction (TIMI) phase II trial: Outcome comparison of a “conservative strategy” in community versus tertiary hospitals by Feit, Frederick, Mueller, Hiltrud S, Braunwald, Eugene, Ross, Richard, Hodges, Morrison, Herman, Michael V, Knatterud, Genell L

“…In the conservative strategy arm of phase II of the Thrombolysis in Myocardial Infarction (TIMI) trial, 1,461 patients were treated with intravenous…”
Get full text

Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease : The Bypass Angioplasty Revascularization Investigation (BARI) by Investigators, The BARI

“…Patients with diabetes mellitus have increased morbidity and mortality after coronary revascularization. The Bypass Angioplasty Revascularization Investigation…”
Get full text

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial) by Chew, Derek P., Lincoff, A. Michael, Gurm, Hitinder, Wolski, Katherine, Cohen, David J., Henry, Tim, Feit, Frederick, Topol, Eric J.

“…Among patients who undergo percutaneous coronary intervention, renal impairment is associated with an excessive risk of bleeding and ischemic events…”
Get full text

Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials by Chew, Derek P, Bhatt, Deepak L, Kimball, William, Henry, Timothy D, Berger, Peter, McCullough, Peter A, Feit, Frederick, Bittl, John A, Lincoff, A.Michael

“…Chronic kidney disease is associated with an increased risk of ischemic and bleeding events after percutaneous coronary intervention (PCI). The direct thrombin…”
Get full text